Prevenar 13 + Pneumovax 23 clinical trials

Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma

This study compares different pneumonia vaccines in adults with lymphoma. We're looking at how well the immune system responds to two common vaccines given separately versus one newer vaccine, to see which offers better protection against pneumonia.